When was gabapentin approved for marketing in the USA and for what indications may it be promoted?
Gabapentin received final approval for marketing in the USA on 30 December 1993 and is labeled only for use as an anticonvulsant. It is also widely used to treat individuals suffering from many kinds of pain problems, tremors, restless legs syndrome, hot flashes associated with menopause, and various psychiatric disorders.
Related Questions
- Im an Independent Consultant for a direct marketing company that makes products in the USA, can I advertise?
- When was gabapentin approved for marketing in the USA and for what indications may it be promoted?
- When was topiramate approved for marketing in the USA and for what indications may it be promoted?